Table 5. Total costs prevented over lifetime of Benefit Cohort Population.
| Direct Costs Prevented | Indirect Costs Prevented | ||||||
| Population Group | Population Subgroup | Benefit Cohort Population (millions) | Acute Disease (US$MM) | Chronic Disease (US$MM) | Acute Disease (US$MM) | Chronic Disease (US$MM) | Total Costs Prevented (US$MM) |
| 1. Protected from acquiring infection (and subsequent disease) | a) Newborns | 2.2 | $71 | $6 | $207 | $1,444 | $1,727 |
| b) Protected from infection | 0.5 | $24 | $2 | $75 | $532 | $633 | |
| Subtotal | 2.7 | $95 | $8 | $282 | $1,975 | $2,360 | |
| 2. Protected from disease progression | a) Subclinical morbidity | 9.4 | $584 | $49 | $1,765 | $12,146 | $14,544 |
| b) Clinical morbidity | 19.3 | $528 | $89 | $1,596 | $2,698 | $4,911 | |
| Subtotal | 28.7 | $1,112 | $138 | $3,361 | $14,844 | $19,455 | |
| Total | 31.4 | $1,207 | $146 | $3,643 | $16,819 | $21,815 | |